Management focuses on rapid reperfusion and prevention of further myocardial injury.
π₯ 1. Immediate (Emergency) Management
Confirm diagnosis: ECG showing ST elevation in β₯2 contiguous leads or new LBBB with ischemic symptoms.
Assess vitals: Airway, Breathing, Circulation (ABCs)
Obtain IV access and start continuous cardiac monitoring.
Draw blood: cardiac enzymes (troponin), CBC, electrolytes, renal function, coagulation profile.
(Given immediately unless contraindicated)
| Drug | Purpose | Key Notes |
|---|---|---|
| M β Morphine | Pain relief, reduces sympathetic tone | Use cautiously β may mask worsening symptoms |
| O β Oxygen | For Oβ saturation < 90% | Routine Oβ not needed if sat β₯ 90% |
| N β Nitrates | Vasodilation, reduces preload | Avoid in RV infarction, hypotension, or PDE-5 use |
| A β Aspirin | Antiplatelet | 162β325 mg chewed immediately |
| B β Beta-blocker | Reduces Oβ demand, arrhythmia risk | Avoid if hypotensive, bradycardic, or in HF |
Additional:
P2Y12 inhibitor: Clopidogrel, Ticagrelor, or Prasugrel
Anticoagulant: Unfractionated heparin or enoxaparin
Preferred method if available within 90 minutes (“door-to-balloon” time).
Balloon angioplasty and stenting reopen the blocked artery.
Goal: restore blood flow (TIMI grade 3) and minimize infarct size.
If PCI unavailable within 120 minutes, give fibrinolytic therapy within 30 minutes (“door-to-needle” time).
Agents: Tenecteplase, Alteplase (tPA), Reteplase
Indications: β€12 hours since symptom onset and no contraindications.
Absolute contraindications:
Active bleeding
Prior intracranial hemorrhage
Known cerebral aneurysm, AV malformation, or neoplasm
Ischemic stroke within 3 months
| Medication | Purpose |
|---|---|
| Antiplatelets (Aspirin + P2Y12 inhibitor) | Dual antiplatelet therapy for β₯12 months |
| Anticoagulant | Heparin during PCI or post-lysis |
| Statins (High-intensity) | Plaque stabilization (e.g., Atorvastatin 80 mg) |
| ACE Inhibitor/ARB | Start within 24 hours (if no hypotension) |
| Aldosterone antagonist | In LV dysfunction or diabetes, if KβΊ <5 and Cr <2.5 |
| Beta-blocker | Continue unless contraindicated |
Monitor for complications: arrhythmias, heart failure, mechanical rupture.
Lifestyle modifications: smoking cessation, diet, exercise.
Cardiac rehabilitation: structured exercise and education program.
Follow-up: Regular monitoring of lipids, blood pressure, diabetes control.
| Step | Target Time | Treatment |
|---|---|---|
| ECG + Diagnosis | <10 min | Confirm STEMI |
| Reperfusion | PCI <90 min or Fibrinolysis <30 min | Restore blood flow |
| Antiplatelets & Anticoagulants | Immediately | Prevent new clots |
| Long-term therapy | After stabilization | Statin, ACEI/ARB, beta-blocker, rehab |
Would you like me to include a flowchart or timeline showing the STEMI management steps from ER arrival to discharge?
+++++++++++++++++++++
Here’s a clear, step-by-step flowchart and timeline for the management of ST-segment elevation myocardial infarction (STEMI) β from emergency arrival to hospital discharge and long-term care.
Goal: Early recognition and transport
π Call emergency services (EMS)
Perform 12-lead ECG if available
Give Aspirin 162β325 mg chewed
Provide Oxygen if SpOβ < 90%
Consider Nitroglycerin (if BP stable, no RV infarct)
Alert PCI-capable hospital (“STEMI alert”)
Goal: Confirm STEMI and start treatment
Rapid ECG confirmation β ST elevation β₯1 mm in β₯2 contiguous leads
Obtain IV access, cardiac monitoring
Draw labs (cardiac enzymes, CBC, electrolytes, coagulation)
Begin MONA-B:
Morphine (for pain)
Oxygen (if hypoxic)
Nitrates (if appropriate)
Aspirin
Beta-blocker
β Decision Point:
Can PCI be performed within 90 min of arrival?
Goal: Door-to-balloon time <90 minutes
Procedure: Angioplasty + stent placement
Adjunct meds:
P2Y12 inhibitor: Clopidogrel / Ticagrelor / Prasugrel
Anticoagulant: Heparin or Enoxaparin
Goal: Door-to-needle time <30 minutes
Agents: Alteplase (tPA), Tenecteplase, or Reteplase
Contraindications: Prior intracranial bleed, stroke <3 months, active bleeding, aortic dissection
Continue heparin and dual antiplatelet therapy
Goals: Prevent reocclusion, stabilize myocardium
Monitor continuously (for arrhythmias, reinfarction)
Start or continue:
Aspirin + P2Y12 inhibitor (dual therapy)
Beta-blocker
ACE inhibitor or ARB (if no hypotension)
High-intensity statin (e.g., Atorvastatin 80 mg)
Evaluate LV function (Echocardiogram)
Manage complications:
Arrhythmias β antiarrhythmics or pacing
Heart failure β diuretics, inotropes
Mechanical β surgery if needed (e.g., papillary muscle rupture)
Goals: Recovery, risk modification
Mobilize early (if stable)
Reassess medications
Educate patient:
Smoking cessation
Diet (low fat, low sodium)
Exercise (cardiac rehab referral)
Diabetes and BP control
Core Medications at Discharge:
| Class | Example | Duration |
|---|---|---|
| Antiplatelet | Aspirin (indefinite) | lifelong |
| P2Y12 inhibitor | Clopidogrel / Ticagrelor | 12 months |
| Beta-blocker | Metoprolol | lifelong unless contraindicated |
| ACEI/ARB | Lisinopril / Losartan | long-term |
| Statin | Atorvastatin 80 mg | lifelong |
Goals: Secondary prevention, cardiac rehab
Cardiac Rehabilitation Program
Risk factor control:
BP <130/80 mmHg
LDL <70 mg/dL
HbA1c <7% (if diabetic)
Lifestyle: Diet, exercise, no smoking, stress management
Regular follow-up: Cardiology + primary care
CHEST PAIN β ECG (β€10 min) β ST-ELEVATION? β YES β Initiate MONA-B + DAPT + Anticoagulant β PCI Available β€90 min? β β YES β Primary PCI (goal β€90 min) β NO β Fibrinolysis (goal β€30 min) β Reassess β Rescue PCI if fibrinolysis fails β Post-reperfusion meds (BB, ACEI, Statin) β Monitor 24β48 hr β Echo β Complications β Discharge β Dual Antiplatelet, Rehab, Follow-up
Would you like me to create a visual infographic (timeline + color-coded flowchart) for this STEMI management outline β suitable for teaching slides or clinical reference?
Anticoagulate/Fibrinolysis/ASA
011. Percutaneous Coronary Intervention
012. Timely PCI is not available
0122. Dosage of Fibrinolytic Agent
014. No Contraindications to PCI
02. Timely PCI is not available